1. Heath H. 3rd, Hodgson S.F., Kennedy M.A. Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community. N. Engl. J. Med. 1980, 302: 189–193.
2. Teh B.T., Esapa C., Houlston R., Grandell U., Farnebo F., Nordenskjod M. Familial isolated hyperparathyroidism associated with a constitutional MEN1 mutations. Am. J. Hum. Genet. 1998, 18: 1544–1549.
3. Teh B.T., Farnebo F., Twigg S., et al. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21–q32 in a subset of families. J. Clin. Endocrinol. Metab. 1998, 83: 2114–2120.
4. Bergwitz C., Bremer B., Soudah B., Mayr B., Brabant G., Familial isolated parathyroid adenoma in a consanguineous family. J. Endocrinol. Invest. 2001, 5: 349–355.
5. Bilezikian J.P., Silverberg S., Gartenberg F., et al. Clinical presentation of primary hyperparathyroidism. In: Bilezikian J.P., Marcus R., Levine M.A. (Eds.), The parathyroids: Basic and clinical concepts. Raven Press, New York, 1994, p. 457.